Clinical prediction of incident heart failure risk: a systematic review and meta-analysis

Hong Yang,Kazuaki Negishi,Petr Otahal,Thomas H Marwick
DOI: https://doi.org/10.1136/openhrt-2014-000222
2015-04-01
Open Heart
Abstract:BACKGROUND: Early treatment may alter progression to overt heart failure (HF) in asymptomatic individuals with stage B HF (SBHF). However, the identification of patients with SBHF is difficult. This systematic review sought to examine the strength of association of clinical factors with incident HF, with the intention of facilitating selection for HF screening.METHODS: Electronic databases were systematically searched for studies reporting risk factors for incident HF. Effect sizes, typically HRs, of each risk variable were extracted. Pooled crude and adjusted HRs with 95% CIs were computed for each risk variable using a random-effects model weighted by inverse variance.RESULTS: Twenty-seven clinical factors were identified to be associated with risk of incident HF in 15 observational studies in unselected community populations which followed 456 850 participants over 4-29 years. The strongest independent associations for incident HF were coronary artery disease (HR=2.94; 95% CI 1.36 to 6.33), diabetes mellitus (HR=2.00; 95% CI 1.68 to 2.38), age (HR (per 10 years)=1.80; 95% CI 1.13 to 2.87) followed by hypertension (HR=1.61; 95% CI 1.33 to 1.96), smoking (HR=1.60; 95% CI 1.45 to 1.77), male gender (HR=1.52; 95% CI 1.24 to 1.87) and body mass index (HR (per 5 kg/m(2))=1.15; 95% CI 1.06 to 1.25). Atrial fibrillation (HR=1.88; 95% CI 1.60 to 2.21), left ventricular hypertrophy (HR=2.46; 95% CI 1.71 to 3.53) and valvular heart disease (HR=1.74; 95% CI 1.07 to 2.84) were also strongly associated with incident HF but were not examined in sufficient papers to provide pooled hazard estimates.CONCLUSIONS: Prediction of incident HF can be calculated from seven common clinical variables. The risk associated with these may guide strategies for the identification of high-risk people who may benefit from further evaluation and intervention.
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to evaluate the strength of the association between clinical factors and the risk of new - onset heart failure (HF) through systematic review and meta - analysis, in the hope of being able to identify high - risk individuals, thereby guiding further screening and intervention measures. Specifically, the researchers hope to provide a basis for formulating a practical clinical score for heart failure screening by identifying common clinical variables related to new - onset heart failure, thereby promoting the identification of early asymptomatic patients so as to adopt cardioprotective strategies to prevent disease progression. ### Research Background - **Heart Failure (HF)**: The incidence and prevalence of heart failure are increasing, and approximately 23 million people are affected globally. In the United States, 550,000 new cases of heart failure are diagnosed each year. - **Importance of Early Treatment**: Early treatment can change the process of asymptomatic individuals (i.e., patients with stage B heart failure) developing into overt heart failure. However, it is very difficult to identify these stage B heart failure patients. ### Research Methods - **Literature Search**: Electronically searched databases systematically for studies reporting risk factors for new - onset heart failure. - **Data Analysis**: Extracted the effect size (usually hazard ratio HR) of each risk variable, and used a random - effects model to calculate the pooled crude and adjusted HRs and their 95% confidence intervals (CI) for each risk variable. ### Main Results - **Related Clinical Factors**: The study identified 27 clinical factors related to the risk of new - onset heart failure, among which the strongest independent associated factors include: - Coronary artery disease (HR = 2.94; 95% CI 1.36 to 6.33) - Diabetes (HR = 2.00; 95% CI 1.68 to 2.38) - Age (for every 10 - year increase, HR = 1.80; 95% CI 1.13 to 2.87) - Hypertension (HR = 1.61; 95% CI 1.33 to 1.96) - Smoking (HR = 1.60; 95% CI 1.45 to 1.77) - Male (HR = 1.52; 95% CI 1.24 to 1.87) - Body mass index (for every 5 kg/m² increase, HR = 1.15; 95% CI 1.06 to 1.25) ### Conclusions - **Predicting New - Onset Heart Failure**: The risk of new - onset heart failure can be calculated through seven common clinical variables. The identification of these risk factors can help develop strategies for identifying high - risk populations who may benefit from further evaluation and intervention. - **Impact on Clinical Practice**: Early detection of ventricular dysfunction in asymptomatic patients allows for the adoption of cardioprotective measures to prevent disease progression. Therefore, the assessment of heart failure risk is a crucial step in selecting appropriate patients for imaging examinations. ### Future Directions - **Validating the Validity of the Risk Score**: It is necessary to prospectively validate the predictive value of the risk score, the benefits of imaging monitoring, and the cost - effectiveness of screening for stage A heart failure in the community. ### Limitations - **Heterogeneity**: High heterogeneity among studies (high I² value) indicates significant differences among the studies. - **Data Limitations**: Due to the inability to obtain individual - level data, researchers can only propose a combined risk measure as an indicator of risk magnitude, rather than an accurate risk estimate. Overall, this study provides important scientific evidence for the early prevention and management of heart failure.